Effects of Low-volume Aerobic Interval Training in Overweight Individuals at Increased Cardiometabolic Risk
BELITA
Low-volume Aerobic Interval Training in Overweight Individuals at Increased Cardiometabolic Risk: Impact of Training Intensity on Cardiorespiratory Fitness, Cardiometabolic Risk Profile and Exercise Adherence
1 other identifier
interventional
154
1 country
1
Brief Summary
The main purpose of this study is to compare the impact of aerobic interval training intensity on exercise adherence and changes in cardiorespiratory fitness, cardiometabolic risk profile, body composition, inflammatory markers and subjective health outcomes after a 12-week intervention trial in overweight individuals at increased cardiometabolic risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2017
CompletedFirst Posted
Study publicly available on registry
October 10, 2017
CompletedStudy Start
First participant enrolled
November 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2020
CompletedSeptember 14, 2020
September 1, 2020
2.3 years
September 27, 2017
September 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cardiorespiratory Fitness (CRF)
CRF will be assessed by measuring Maximum Oxygen uptake (VO2max)
12 weeks (baseline to 12 week follow-up assessment)
Secondary Outcomes (8)
Metabolic Syndrome Z-Score (MetS-Z-Score)
12 weeks (baseline to 12 week follow-up assessment)
Body Composition
12 weeks (baseline to 12 week follow-up assessment)
Insulin sensitivity
12 weeks (baseline to 12 week follow-up assessment)
Inflammation
12 weeks (baseline to 12 week follow-up assessment)
Health-related quality of life
12 weeks (baseline to 12 week follow-up assessment)
- +3 more secondary outcomes
Study Arms (4)
Control
EXPERIMENTALNutritional therapy / no exercise
HIIT
EXPERIMENTALHigh-intensity interval training (HIIT) at 90% heart rate maximum (HRmax) combined with Nutritional therapy
MIIT-HR
EXPERIMENTALHeart rate based moderate-intensity interval training (MIIT-HR) at 70% heart rate maximum (HRmax) combined with Nutritional therapy
MIIT-LT
EXPERIMENTALLactate threshold based moderate-intensity interval training (MIIT-LT) at 105% of lactate threshold (corresponding \~70-75% HRmax) combined with Nutritional therapy
Interventions
Individualized, weight-reducing nutritional therapy and counseling, during a study period of 12 weeks
Procedures: Nutritional therapy (individualized, weightreducing nutritional therapy and counseling) during a study period of 12 weeks combined with supervised ergometer-based high-intensity interval training (HIIT). HIIT: * 2 sessions per week * 5x1 min at 80-95% HRmax * time-effort per week: \~30 min
Procedures: Nutritional therapy (individualized, weightreducing nutritional therapy and counseling) during a study period of 12 weeks combined with supervised ergometer-based moderate-intensity interval training on the basis of HRmax (MIIT-HR). MIIT-HR: * 2 sessions per week * 5x1 min at 65-79% HRmax * time-effort per week: \~30 min
Procedures: Nutritional therapy (individualized, weightreducing nutritional therapy and counseling) during a study period of 12 weeks combined with supervised ergometer-based moderate-intensity interval training on the basis of lactate threshold (MIIT-LT). MIIT-LT: * 2 sessions per week * session 1: 2x4 min / session 2: 5x1 min, each at 105% LT * time-effort per week: \~30 min
Eligibility Criteria
You may qualify if:
- Body Mass Index \>/=30
- presence of at least 2 cardiometabolic risk factors
You may not qualify if:
- Healthy persons or patients under age
- Overweight persons without any additional cardiometabolic risk factors
- Pregnancy, Lactation
- Psychological disorders, epilepsy, sever neurological disorders
- Participation in other exercise- or nutrition studies within the last 6 months
- acute cardiovascular disease
- malignant disease
- Electronic implants (defibrillator, pacemaker)
- Persons in mental hospitals by order of authorities or jurisdiction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports,
Erlangen, 91052, Germany
Related Publications (1)
Reljic D, Frenk F, Herrmann HJ, Neurath MF, Zopf Y. Low-volume high-intensity interval training improves cardiometabolic health, work ability and well-being in severely obese individuals: a randomized-controlled trial sub-study. J Transl Med. 2020 Nov 7;18(1):419. doi: 10.1186/s12967-020-02592-6.
PMID: 33160382DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dejan Reljic, Dr.
University Erlangen Nuremberg Medical School
- PRINCIPAL INVESTIGATOR
Yurdaguel Zopf, Prof.
University Erlangen Nuremberg Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome Assessors involved in data analysis will not be aware of the arm to which the participants were allocated (single-blinded masking).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2017
First Posted
October 10, 2017
Study Start
November 1, 2017
Primary Completion
February 15, 2020
Study Completion
April 15, 2020
Last Updated
September 14, 2020
Record last verified: 2020-09